Go Pro
→ I’ll Keep This Short… (Huge AI Opportunity) (From Traders Agency) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$87.51
-0.4%		$76.98
$47.31
▼
$88.58
$3.98B0.52747,182 shs657,064 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$127.84
$115.03
$100.85
▼
$212.00
$4.21B1.3617,294 shs1.83 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$125.06
-0.2%		$97.41
$62.00
▼
$126.14
$4.25B0.611.48 million shs1.06 million shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$20.41
$21.59
$16.67
▼
$42.71
$1.16B0.891.92 million shs1.76 million shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%+2.33%+15.06%+67.24%+62.41%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.00%+9.11%+10.08%+9.41%-19.34%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%+3.30%+33.74%+47.32%+17.53%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.00%+9.61%-2.30%-22.84%-46.86%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$87.51
-0.4%		$76.98
$47.31
▼
$88.58
$3.98B0.52747,182 shs657,064 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$127.84
$115.03
$100.85
▼
$212.00
$4.21B1.3617,294 shs1.83 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$125.06
-0.2%		$97.41
$62.00
▼
$126.14
$4.25B0.611.48 million shs1.06 million shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$20.41
$21.59
$16.67
▼
$42.71
$1.16B0.891.92 million shs1.76 million shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%+2.33%+15.06%+67.24%+62.41%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.00%+9.11%+10.08%+9.41%-19.34%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%+3.30%+33.74%+47.32%+17.53%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.00%+9.61%-2.30%-22.84%-46.86%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Haemonetics Corporation stock logo
HAE
Haemonetics
2.73
Moderate Buy$90.893.87% Upside
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.94
Moderate Buy$179.3640.30% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
2.07
Hold$109.86-12.16% Downside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.19
Hold$28.0037.19% Upside

Current Analyst Ratings Breakdown

Latest PRCT, ITGR, HAE, and IRTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$105.00
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$96.00
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Barrington Research logo
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$95.00
8/7/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$255.00 ➝ $192.00
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$79.00 ➝ $92.00
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$62.00 ➝ $86.00
8/7/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$180.00 ➝ $168.00
8/6/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$84.00 ➝ $96.00
8/5/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$34.00 ➝ $28.00
8/5/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$21.00
8/5/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$23.00
(Data available from 8/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.35B2.94$7.55 per share11.59$17.14 per share5.11
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$747.14M5.64N/AN/A$4.74 per share26.97
Integer Holdings Corporation stock logo
ITGR
Integer
$1.85B2.29$10.34 per share12.09$49.85 per share2.51
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$308.05M3.77N/AN/A$6.55 per share3.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Haemonetics Corporation stock logo
HAE
Haemonetics
$97.31M$2.0442.8915.321.777.12%27.55%9.65%N/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.43N/A101.46N/A-1.69%10.11%1.53%10/29/2026 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$3.6634.1718.502.996.97%12.79%6.48%10/22/2026 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$95.57M-$1.94N/AN/AN/A-32.53%-30.62%-22.10%N/A

Latest PRCT, ITGR, HAE, and IRTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q1 2027
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.08$1.14+$0.06$0.72$327.86 million$339.38 million
8/6/2026Q2 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.04$0.58+$0.62-$0.01$219.30 million$224.17 million
8/4/2026Q2 2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.4619-$0.47-$0.0081-$0.47$92.77 million$94.50 million
8/3/2026Q2 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.38$1.60+$0.22$0.69$451.07 million$464.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Haemonetics Corporation stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Haemonetics Corporation stock logo
HAE
Haemonetics
1.40
3.08
1.91
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.50
3.86
3.74
Integer Holdings Corporation stock logo
ITGR
Integer
0.75
3.73
2.41
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.15
6.55
5.35

Institutional Ownership

CompanyInstitutional Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
99.67%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%

Insider Ownership

CompanyInsider Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
2.07%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
4.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Haemonetics Corporation stock logo
HAE
Haemonetics
3,00945.45 million44.56 millionOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.96 million32.64 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00033.99 million33.62 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43056.92 million54.64 millionOptionable

Recent News About These Companies

PROCEPT BioRobotics (PRCT) Stock Sees Fair Value Falls As Analysts Cut Growth Views
August 9 at 7:10 PM  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/procept-biorobotics-prct-stock-sees-161239945.html
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRCT
August 9 at 2:57 PM  |  newsfilecorp.comN
PROCEPT BioRobotics Corporation Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
August 9 at 10:55 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/09/3341485/0/en/procept-biorobotics-corporation-investors-september-22-2026-deadline-in-securities-fraud-class-action-lawsuit-contact-kessler-topaz-meltzer-check-llp.html
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT
August 9 at 9:17 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/09/3341482/673/en/rosen-a-global-and-leading-law-firm-encourages-procept-biorobotics-corporation-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-prct.html
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRCT
August 8 at 2:34 PM  |  newsfilecorp.comN
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of ...
August 7 at 3:03 PM  |  enidnews.comE
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud ...
August 7 at 3:03 PM  |  enidnews.comE
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP
August 7 at 3:02 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341337/32716/en/procept-biorobotics-corporation-securities-fraud-class-action-result-of-undisclosed-inventory-issues-and-approximately-18-stock-decline-investors-may-contact-reed-kathrein-at-hagen.html
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
August 7 at 2:59 PM  |  newsfilecorp.comN
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRCT
August 7 at 2:24 PM  |  newsfilecorp.comN
Kaplan Fox Reminds PROCEPT BioRobotics Corporation (PRCT) Investors of an Approaching Securities Class Action Deadline on September 22, 2026
August 7 at 2:15 PM  |  newsfilecorp.comN
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
August 7 at 10:51 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341233/35454/en/procept-biorobotics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-procept-biorobotics-.html
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors with Significant Losses to Contact the Firm Before September 22, 2026
August 7 at 10:50 AM  |  financialpost.comF
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors with Significant Losses to Contact the Firm Before September 22, 2026
August 7 at 10:45 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341230/1020/en/kaplan-fox-encourages-procept-biorobotics-corporation-nasdaq-prct-investors-with-significant-losses-to-contact-the-firm-before-september-22-2026.html
PRCT Deadline Alert: The Gross Law Firm Reminds PROCEPT BioRobotics Corporation (PRCT) Investors of Securities Class Action Deadline on September 22, 2026
August 7 at 10:10 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341169/0/en/prct-deadline-alert-the-gross-law-firm-reminds-procept-biorobotics-corporation-prct-investors-of-securities-class-action-deadline-on-september-22-2026.html
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law
August 7 at 10:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341151/0/en/prct-investors-have-opportunity-to-lead-procept-biorobotics-corporation-securities-fraud-lawsuit-with-sbs-law.html
$PRCT Court News: PROCEPT BioRobotics Securities Fraud Class Action Deadline is Imminent – Contact BFA Law before September 22
August 7 at 6:18 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341004/0/en/prct-court-news-procept-biorobotics-securities-fraud-class-action-deadline-is-imminent-contact-bfa-law-before-september-22.html
Wells Fargo & Company Downgrades PROCEPT BioRobotics (NASDAQ:PRCT) to Equal Weight
August 7 at 2:36 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30945713
PRCT Shareholder Alert: PROCEPT BIOROBOTICS CORPORATION Securities Class Action Lawsuit - ...
August 6, 2026  |  caledonianrecord.comC
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines - PRCT
August 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-procept-biorobotics-corporation-of-class-action-lawsuit-and-upcoming-deadlines--prct-302845532.html
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Lowered to Equal Weight at Wells Fargo & Company
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/procept-biorobotics-nasdaqprct-rating-lowered-to-equal-weight-at-wells-fargo-company-2026-08-05/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
PayPal logo displayed on a curved reception desk in a modern office lobby with city skyline views.
PayPal Stock Surges on $53 Billion Stripe-Advent Buyout Bid
By Jeffrey Neal Johnson | July 16, 2026
Man resembling Michael Burry in a suit stands between DraftKings and Flutter Entertainment logos on screens in a trading floor setting.
Why "Big Short" Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks
By Leo Miller | July 12, 2026
Haemonetics stock logo

Haemonetics NYSE:HAE

$87.50 -0.34 (-0.38%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$84.70 -2.80 (-3.20%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$127.84 0.00 (0.00%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$137.99 +10.15 (+7.94%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Integer stock logo

Integer NYSE:ITGR

$125.06 -0.21 (-0.16%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$125.24 +0.17 (+0.14%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$20.41 0.00 (0.00%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$20.32 -0.09 (-0.47%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas